Sid Hopps @DjangoHopps

Founder/CEO Adze Biotechnology: Developing a systemically deliverable oncolytic immunotherapy platform. #glioblastoma, #melanoma, #breastcancer Joined February 2011

Tweets

884
Followers

475
Following

2K
Likes

3K

Baseball’s Greatest Moments @BBGreatMoments

3 months ago

Someone made a baseball movie montage and it actually deserves an Oscar.

59 482 2K 185K 1K

Download Video

Baseball @mlbelites_

2 years ago

This pitch just doesn’t make sense 😳

135 345 3K 669K 96

Download Video

Andrew Pannu @andrewpannu

3 years ago

Approval of PD-1/PD-L1 mono and combo therapies in major tumor types Source: BoA

1 7 42 6K 16

Download Image

Andrew Pannu @andrewpannu

3 years ago

Gene therapy landscape I pulled together 42 public companies and charted the preclinical & clinical assets of each, segmented by approach & vector Some takeaways:

29 190 1K 310K 560

Download Image

Happy to share that our work examining the benefits of adding chemotherapy to immunotherapy in NSCLC is now published in Nat Comms. We found that chemo adds no long-term or synergistic benefit to IO monotherapy. But! [1/4] nature.com/articles/s4146…

5 48 220 46K 30

Bradford Hardin @bradford_hardin

3 years ago

I just realized you can drag an email from your Outlook inbox onto your calendar and simply schedule a time to do the task rather than leaving the email in a list of flagged items to complete. GAME CHANGER.

24 26 431 0 81

Julian Lennon @JulianLennon

3 years ago

It’s Amazing who you run into in an airport Lounge! None other than Uncle Paul…. So, so lovely, and what are the chances… Thankful…. ❤️🙏🏻😘

2K 13K 200K 0 1K

Download Image

Phillies Muse @Phillies_Muse

3 years ago

Bryce Harper, but Moneyball

789 10K 57K 0 2K

Download Video

Curtis Houck @CurtisHouck

3 years ago

#BREAKING: Here was the official @BBC "News Report" on Queen Elizabeth II's passing, followed by God Save the Queen. "The BBC is interrupting its normal programs to bring you an important announcement. This is BBC News...Buckingham Palace has announced the death of Her Majesty"

10 165 352 0 53

Download Video

Baseball @mlbelites_

3 years ago

Never forget the time Ohtani hit a ball THROUGH the Tokyo dome 😂

226 5K 51K 0 1K

Download Video

Joyce Lee @joycevlee

3 years ago

Why do some triple negative breast cancer patients respond to anti-PD-L1/PD-1 immune checkpoint blockade, while others do not? We investigated this question nature.com/articles/s4146… @goga_lab @UCSFCancer #breastcancer Tweetorial 👇

3 83 250 0 54

Mark Awad @DrMarkAwad

3 years ago

Does high tumor mutational burden (#TMB) impact immunotherapy outcomes in #NSCLC? This has been a challenging biomarker to interpret and incorporate into clinical practice. We looked at >1500 patients w/NSCLC treated with PD-(L)1 inhibitors: ja.ma/3Qrvf5y in @JAMAOnc.

4 75 241 0 26

Mike Foote @MikeFooteMD

3 years ago

Absolutely unbelievable data by @AndreaCercek @MSKCancerCenter at @ASCO #ASCO2022: 100% CR rate in 14 consecutive high risk (90%+st3) rectal cancer pts w/ Dostarlimab PD1 monotherapy. NO PATIENT REQUIRED CHEMO/SURGERY/RT. #immunoablative therapy is here + published now in @NEJM

12 131 514 0 21

Download Image

Neeraj Agarwal, MD, FASCO @neerajaiims

3 years ago

#ASCO22 @montypal presents results from Cosmic-021 bladder cancer cohorts Rx with Cabozantinib + atezolizumab 👉 design, ORRs, conclusions 👇clinical activity present. @OncoAlert @ASCO @BladderCancerUS @PGrivasMDPhD @DrChoueiri giving shoutout to pioneering work of @apolo_andrea

Neeraj Agarwal, MD, FASCO @neerajaiims

3 years ago

1 39 81 0 5

Download Image

1 24 42 0 3

Download Image

Abhishek Tripathi @AbhiTrip87

3 years ago

#ASCO22 @ASCO Abstract#5081: Long term outcomes with ADT+/- docetaxel in the EA3805 CHAARTED trial (abstract#5081) @eaonc @ChrisSweens1 1. 8-year OS 35% in ADT+ D arm 2. Disease volume and de novo met. HSPC continue to predict benefit from early docetaxel

0 35 73 0 11

Download Image

UroToday.com @urotoday

3 years ago

Comparison of clinical outcomes between ADT with up-front abiraterone and bicalutamide for #Japanese patients with #LATITUDE high-risk #ProstateCancer in a real-world multicenter analysis. Presented by Taku Naiki, MD, PhD. #AUA22 coverage by @WallisCJD > bit.ly/3PoBCWA

0 2 6 0 1

Download Image

EllisLab_ @EllisLab_

3 years ago

Landscape of helper and regulatory antitumour CD4+ T cells in melanoma | Nature nature.com/articles/s4158…

0 3 5 0 0

Nathan Reticker-Flynn @RetickerFlynn

3 years ago

Tumors spread to lymph nodes before they metastasize to distant tissues, but for over a century scientists have debated whether this matters. It does. Check out our paper online now @CellCellPress @CellPressNews cell.com/cell/fulltext/… 1/15

40 491 2K 0 283

Andrea R. Filippi @AndrearicFili

3 years ago

A second attempt following your suggestions, again comments are welcome, thanks to all

Andrea R. Filippi @AndrearicFili

3 years ago

A second attempt following your suggestions, again comments are welcome, thanks to all https://t.co/XsWxflJnGb

6 42 95 0 18

Download Image

4 16 51 0 9

Download Image

Alex Ritter, PhD @RitterLab

3 years ago

Small but mighty! This is a video of a killer T cell of the immune system destroying a monstrous ovarian cancer cell. I recently captured this data on a spinning disc confocal microscope.